Skip to main content

Advertisement

SpringerLink
Log in

Erythromelalgia

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

No treatment is consistently effective in the management of patients with erythromelalgia. There is a dearth of adequate studies examining the response of erythromelalgia to treatment. Most recommendations are suggested based on case reports, small case series, and anecdotal reports. The management of erythromelalgia is difficult and frequently involves a multidisciplinary approach. An approach to management of individuals with erythromelalgia includes patient education, learning to avoid episodes, relieving discomfort of the episodes, controlling secondary and underlying factors, and use of drugs used to control erythromelalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Mork C, Asker CL, Salerud EG, Kvernebo K: Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol 2000, 114:643–646.

    Article  PubMed  CAS  Google Scholar 

  2. Davis MD, Rooke TW, Sandroni P: Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia. J Invest Dermatol 2000, 115:1166–1167.

    Article  PubMed  CAS  Google Scholar 

  3. Davis M, Sandroni P, Harper CM, et al.: Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromuscular Dis 1999, 1:57–63.

    Article  Google Scholar 

  4. Drenth JP, te Morsche RH, Guillet G, et al.: SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005, 124:1333–1338.

    Article  PubMed  CAS  Google Scholar 

  5. Davis MD, O’Fallon WM, Rogers RS 3rd, Rooke TW: Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol 2000, 136:330–336. This paper reviews the presentation, natural history, and prognosis in 168 patients with erythromelalgia. In addition, a survey of patients documents quality-of-life scores and tabulates their self-reported response to treatment.

    Article  PubMed  CAS  Google Scholar 

  6. Mork C, Salerud EG, Asker CL, Kvernebo K: The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia: a double-blind, crossover, placebocompared study. J Invest Dermatol 2004, 122:587–593.

    Article  PubMed  CAS  Google Scholar 

  7. Smith LA, Allen EV: Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat and pain. Am Heart J 1938, 16:175–188.

    Article  Google Scholar 

  8. Michiels JJ, Abels J, Steketee J, et al.: Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 1985, 102:466–471.

    PubMed  CAS  Google Scholar 

  9. Ongenae K, Janssens A, Noens L, et al.: Erythromelalgia: a clue to the diagnosis of polycythemia vera. Dermatology 1996, 192:408–410.

    Article  PubMed  CAS  Google Scholar 

  10. Muhiddin KA, Gallen IW, Harries S, Pearce VR: The use of capsaicin cream in a case of erythromelalgia. Postgrad Med J 1994, 70:841–843.

    PubMed  CAS  Google Scholar 

  11. Rudikoff D, Jaffe IA: Erythromelalgia: response to serotonin reuptake inhibitors. J Am Acad Dermatol 1997, 37:281–283.

    Article  PubMed  CAS  Google Scholar 

  12. Herskovitz S, Loh F, Berger AR, et al.: Erythromelalgia: association with hereditary sensory neuropathy and response to amitriptyline. Neurology 1993, 43:621–622.

    PubMed  CAS  Google Scholar 

  13. McGraw T, Kosek P: Erythromelalgia pain managed with gabapentin. Anesthesiology 1997, 86:988–990.

    Article  PubMed  CAS  Google Scholar 

  14. Bada JL: Treatment of erythromelalgia with propranolol. Lancet 1977, 2:412.

    Article  PubMed  CAS  Google Scholar 

  15. Drenth JP, Michiels JJ, Ozsoylu S: Acute secondary erythermalgia and hypertension in children. Erythermalgia Multidisciplinary Study Group. Eur J Pediatr 1995, 154:882–885.

    Article  PubMed  CAS  Google Scholar 

  16. Kvernebo K: Erythromelalgia—a condition caused by microvascular arteriovenous shunting. VASA 1998, 51(suppl):1–39. This extensive document/thesis reviews all the literature available on erythromelalgia and postulates mechanisms of disease. It also provides information derived from studying 40 patients with this disease.

    Google Scholar 

  17. Littleford RC, Khan F, Belch JJ: Skin perfusion in patients with erythromelalgia. Eur J Clin Invest 1999, 29:588–593.

    Article  PubMed  CAS  Google Scholar 

  18. Kvernebo K, Seem E: Erythromelalgia—pathophysiological and therapeutic aspects. A preliminary report. J Oslo City Hosp 1987, 37:9–12.

    PubMed  CAS  Google Scholar 

  19. Conri CL, Azoulai P, Constans J, et al.: Erythromelalgia and low molecular weight heparin [in French]. Therapie 1994, 49:518–519.

    PubMed  CAS  Google Scholar 

  20. Ozsoylu S, Caner H, Gokalp A: Successful treatment of erythromelalgia with sodium nitroprusside. J Pediatr 1979, 94:619–621.

    PubMed  CAS  Google Scholar 

  21. Ozsoylu S, Coskun T: Sodium nitroprusside treatment in erythromelalgia. Eur J Pediatr 1984, 141:185–187.

    Article  PubMed  CAS  Google Scholar 

  22. Stone JD, Rivey MP, Allington DR: Nitroprusside treatment of erythromelalgia in an adolescent female. Ann Pharmacother 1997, 31:590–592.

    PubMed  CAS  Google Scholar 

  23. Davis MD, Sandroni P: Lidocaine patch for pain of erythromelalgia. Arch Dermatol 2002, 138:17–19.

    Article  PubMed  Google Scholar 

  24. Kuhnert SM, Phillips WJ, Davis MD: Lidocaine and mexiletine therapy for erythromelalgia. Arch Dermatol 1999, 135:1447–1449.

    Article  PubMed  CAS  Google Scholar 

  25. Stricker LJ, Green CR: Resolution of refractory symptoms of secondary erythermalgia with intermittent epidural bupivacaine. Reg Anesth Pain Med 2001, 26:488–490.

    Article  PubMed  CAS  Google Scholar 

  26. D’Angelo R, Cohen IT, Brandom BW: Continuous epidural infusion of bupivacaine and fentanyl for erythromelalgia in an adolescent. Anesth Analg 1992, 74:142–144.

    Article  PubMed  CAS  Google Scholar 

  27. Rauck RL, Naveira F, Speight KL, Smith BP: Refractory idiopathic erythromelalgia. Anesth Analg 1996, 82:1097–1101.

    Article  PubMed  CAS  Google Scholar 

  28. Mohr M, Schneider K, Grosche M, Hildebrandt J: Cervical epidural infusion of morphine and bupivacaine in severe erythromelalgia [in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 1994, 29:371–374.

    PubMed  CAS  Google Scholar 

  29. Trapiella Martinez L, Quiros JF, Caminal Montero L, Fernandez Fernandez C: Treatment of erythromelalgia with buprenorphine [in Spanish]. Rev Clin Esp 1997, 197:792.

    PubMed  CAS  Google Scholar 

  30. Macres S, Richeimer S: Successful treatment of erythromelalgia with intrathecal hydromorphone and clonidine. Clin J Pain 2000, 16:310–313.

    Article  PubMed  CAS  Google Scholar 

  31. Kraus A: Erythromelalgia in a patient with systemic lupus erythematosus treated with clonazepam. J Rheumatol 1990, 17:120.

    PubMed  CAS  Google Scholar 

  32. Sakakibara R, Fukutake T, Kita K, Hattori T: Treatment of primary erythromelalgia with cyproheptadine. J Auton Nerv Syst 1996, 58:121–122.

    Article  PubMed  CAS  Google Scholar 

  33. Calderone DC, Finzi E: Treatment of primary erythromelalgia with piroxicam. J Am Acad Dermatol 1991, 24:145–146.

    Article  PubMed  CAS  Google Scholar 

  34. Pepper H: Primary erythermalgia. Report of a patient treated with methysergide maleate. JAMA 1968, 203:1066–1067.

    Article  PubMed  CAS  Google Scholar 

  35. Vendrell J, Nubiola A, Goday A, et al.: Erythromelalgia associated with acute diabetic neuropathy: an unusual condition. Diabetes Res 1988, 7:149–151.

    PubMed  CAS  Google Scholar 

  36. H’Mila R, Samoud A, Souid M, et al.: Erythermalgia: a rare vascular acrosyndrome [in French]. Arch Fr Pediatr 1991, 48:555–557.

    PubMed  CAS  Google Scholar 

  37. Guillet MH, Le Noach E, Milochau P, et al.: Familial erythermalgia treated with pizotifen [in French]. Ann Dermatol Venereol 1995, 122:777–779.

    PubMed  CAS  Google Scholar 

  38. Drenth JP, Michiels JJ: Treatment options in primary erythermalgia? Am J Hematol 1993, 43:154.

    Article  PubMed  CAS  Google Scholar 

  39. Kasapcopur O, Akkus S, Erdem A, et al.: Erythromelalgia associated with hypertension and leukocytoclastic vasculitis in a child. Clin Exp Rheumatol 1998, 16:184–186.

    PubMed  CAS  Google Scholar 

  40. Cimaz R, Rusconi R, Fossali E, Careddu P: Unexpected healing of cutaneous ulcers in a short child. Lancet 2001, 358:211–212.

    Article  PubMed  CAS  Google Scholar 

  41. Cohen JS: High-dose oral magnesium treatment of chronic, intractable erythromelalgia. Ann Pharmacother 2002, 36:255–260.

    Article  PubMed  Google Scholar 

  42. Confino I, Passwell JH, Padeh S: Erythromelalgia following influenza vaccine in a child. Clin Exp Rheumatol 1997, 15:111–113.

    PubMed  CAS  Google Scholar 

  43. Suh DH, Kim SD, Ahn JS, et al.: A case of erythromelalgia successfully controlled by systemic steroids and pentazocine—is it related to a unique subtype of neutrophilic dermatosis? J Dermatol 2000, 27:204–210.

    PubMed  CAS  Google Scholar 

  44. Postlethwaite JC: Lumbar sympathectomy. A retrospective study of 142 operations on 100 patients. Br J Surg 1973, 60:878–879.

    Article  PubMed  CAS  Google Scholar 

  45. Shiga T, Sakamoto A, Koizumi K, Ogawa R: Endoscopic thoracic sympathectomy for primary erythromelalgia in the upper extremities. Anesth Analg 1999, 88:865–866.

    Article  PubMed  CAS  Google Scholar 

  46. Takeda S, Tomaru T, Higuchi M: A case of primary erythromelalgia (erythermalgia) treated with neural blockade [in Japanese]. Masui 1989, 38:388–3893.

    PubMed  CAS  Google Scholar 

  47. Seishima M, Kanoh H, Izumi T, et al.: A refractory case of secondary erythermalgia successfully treated with lumbar sympathetic ganglion block. Br J Dermatol 2000, 143:868–872.

    Article  PubMed  CAS  Google Scholar 

  48. Zoppi M, Zamponi A, Pagni E, Buoncristiano U: A way to understand erythromelalgia. J Auton Nerv Syst 1985, 13:85–89.

    Article  PubMed  CAS  Google Scholar 

  49. Chakravarty K, Pharoah PD, Scott DG, Barker S: Erythromelalgia—the role of hypnotherapy. Postgrad Med J 1992, 68:44–46.

    Article  PubMed  CAS  Google Scholar 

  50. Graziotti PJ, Goucke CR: Control of intractable pain in erythromelalgia by using spinal cord stimulation. J Pain Symptom Manage 1993, 8:502–504.

    Article  PubMed  CAS  Google Scholar 

  51. Kandel EI: Stereotactic surgery of erythromelalgia. Stereotact Funct Neurosurg 1990, 54-55:96–100.

    Article  PubMed  CAS  Google Scholar 

  52. Sadighi PJ, Arbid EJ: Neurectomy for palliation of primary erythermalgia. Ann Vasc Surg 1995, 9:197–198.

    Article  PubMed  CAS  Google Scholar 

  53. Cohen JS: Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 2000, 43:841–847. This article describes the availability of a support group, called The Erythromelalgia Association, which can be a valuable support to patients with erythromelalgia. The responses of 16 patients to treatment are summarized.

    Article  PubMed  CAS  Google Scholar 

  54. Uchida K, Arita H, Hanaoka K: Successful intravenous administration of low dose ketamine for pain caused by erythromelalgia: report of a case [in Japanese]. Masui 2002, 51:1248–1250.

    PubMed  Google Scholar 

  55. Davis MDP: Combination gel of amitriptyline 1% and ketamine 0.5% for the treatment of refractory erythromelalgia pain: a new treatment option? Arch Dermatol 2006, in press.

  56. Sano S, Itami S, Yoshikawa K: Treatment of primary erythromelalgia with cyclosporine. N Engl J Med 2003, 349:816–817.

    Article  PubMed  Google Scholar 

  57. Shenefelt PD: Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther 2003, 16:114–122.

    Article  PubMed  Google Scholar 

  58. van Genderen PJ, Michiels JJ, van Strik R, et al.: Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin. Thromb Haemost 1995, 73:210–204.

    PubMed  Google Scholar 

  59. Legroux-Crespel E, Sassolas B, Guillet G, et al.: Treatment of familial erythermalgia with the association of lidocaine and mexiletine [in French]. Ann Dermatol Venereol 2003, 130:429–433.

    PubMed  CAS  Google Scholar 

  60. Nathan A, Rose JB, Guite JW, et al.: Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. Pediatrics 2005, 115:e504-e507.

    Article  PubMed  Google Scholar 

  61. Jang HS, Jung D, Kim S, et al.: A case of primary erythromelalgia improved by mexiletine. Br J Dermatol 2004, 151:708–710.

    Article  PubMed  Google Scholar 

  62. Moiin A, Yashar SS, Sanchez JE, Yashar B: Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitor. Br J Dermatol 2002, 146:336–337.

    Article  PubMed  CAS  Google Scholar 

  63. DiCaudo DJ, Kelley LA: Alleviation of erythromelalgia with venlafaxine. Arch Dermatol 2004, 140:621–623.

    Article  PubMed  Google Scholar 

  64. Pandey CK, Singh N, Singh PK: Gabapentin for the treatment of familial erythromelalgia pain. J Assoc Physicians India 2002, 50:1094.

    PubMed  CAS  Google Scholar 

  65. Jaitly V: Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth 2003, 91:302; author reply 302.

    Article  PubMed  CAS  Google Scholar 

  66. Kalgaard OM, Mork C, Kvernebo K: Prostacyclin reduces symptoms and sympathetic dysfunction in erythromelalgia in a double-blind randomized pilot study. Acta Derm Venereol 2003, 83:442–444.

    Article  PubMed  CAS  Google Scholar 

  67. Mork C, Kvernebo K: Erythromelalgia—a mysterious condition? Arch Dermatol 2000, 136:406–409. This editorial provides a thoughtful insight into the controversies surrounding this syndrome.

    Article  PubMed  CAS  Google Scholar 

  68. Sakamoto A: Nerve block therapy for intractable pain: 3 cases of erythlomelalgia [in Japanese]. J Nippon Med Sch 2003, 70:66–68.

    Article  PubMed  Google Scholar 

  69. Dash’ian GG, Sungurov EB: The surgical treatment of erythromelalgia by the destruction of the inlet areas of the posterior spinal nerve roots [in Russian]. Zh Vopr Neirokhir Im N N Burdenko 1995, 2:14–15.

    PubMed  Google Scholar 

  70. Delye H, Lagae L, Vermylen J, Nuttin B: Thalamic stimulation as a treatment for primary erythromelalgia: technical case report. Neurosurgery 2005, 57(4 suppl):E404.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and the Gonda Vascular Center, Mayo Clinic and Mayo Foundation, 200 First Street, SW, 55905, Rochester, MN, USA

    Mark D. P. Davis MD

Authors
  1. Mark D. P. Davis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thom Rooke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, M.D.P., Rooke, T. Erythromelalgia. Curr Treat Options Cardio Med 8, 153–165 (2006). https://doi.org/10.1007/s11936-006-0008-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-006-0008-8

Keywords

Search

Navigation